AK106-001616

· Asahi Kasei Therapeutics Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AK106-001616, covering 2016-07-25 to 2016-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) [Phase 2]